1
|
Qian Z, Xin H, Jia Z, Xia J, Tang Y, Li X, Wu H, Fan Y. MiR-760 exerts a critical regulatory role in glioma proliferation, migration, and invasion by modulating MMP2 expression. J Cancer 2024; 15:3076-3084. [PMID: 38706905 PMCID: PMC11064272 DOI: 10.7150/jca.92518] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2023] [Accepted: 03/21/2024] [Indexed: 05/07/2024] Open
Abstract
Background: Glioma represents the predominant subtype of brain tumor, characterized by an unfavorable prognosis. Current evidence indicates the involvement of microRNAs (miRNAs) in the initiation and progression of glioma malignancies. While miR-760 has been recognized in the context of tumorigenesis, its precise role in gliomas remains insufficiently explored. Methods: In this investigation, we harnessed the GSE25631 database to scrutinize the aberrant expression profiles of microRNAs, whereby the diminished expression of miR-760 in glioblastoma was validated. Our aim was to delineate the expression patterns of microRNA-760 (miR-760) and probe its prognostic significance within the realm of glioma. Employing quantitative real-time polymerase chain reaction, we ascertained the relative expression levels of miR-760 and MMP2 in glioma cell lines. The impact of miR-760 on cell proliferation, migration, and invasion was assessed through Cell Counting Kit-8 (CCK-8), 5-ethynyl-2'-deoxyuridine (EdU), and Transwell assays. Bioinformatics analysis corroborated the downstream target gene of miR-760. Furthermore, a luciferase reporter experiment was conducted to pinpoint MMP2 as the direct target gene of miR-760. The assessment of MMP2 protein levels was accomplished through Western blotting and immunofluorescence techniques. Result: Our data unequivocally revealed a substantial reduction in miR-760 expression within glioma tissues and cell lines. Heightened miR-760 levels exerted a restraining influence on the proliferation, migration, and invasion capabilities of glioma cell lines. The outcomes of our bioinformatics analysis unveiled the ability of miR-760 to engage with and curtail MMP2 expression. Collectively, these findings posit that miR-760 exerts a restraining influence on glioma growth by orchestrating the upregulation of miR-760 along the miR-760/MMP2 axis. Conclusion: The delineation of the miR-760/MMP2 axis promises to broaden our comprehension of the intricate molecular mechanisms underpinning glioma proliferation and may unveil prospective therapeutic avenues for the management of glioma.
Collapse
Affiliation(s)
- Zhengting Qian
- Nanjing Medical University, 210000, Nanjing, JiangSu, China
- Department of Neurosurgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210006, China
| | - Heng Xin
- Nanjing Medical University, 210000, Nanjing, JiangSu, China
- Department of Neurosurgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210006, China
| | - Zhen Jia
- Nanjing Medical University, 210000, Nanjing, JiangSu, China
- Department of Neurosurgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210006, China
| | - Jiageng Xia
- Nanjing Medical University, 210000, Nanjing, JiangSu, China
- Department of Neurosurgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210006, China
| | - Yong Tang
- Department of Neurosurgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210006, China
| | - Xiang Li
- Department of Neurosurgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210006, China
| | - Heming Wu
- Nanjing Medical University, 210000, Nanjing, JiangSu, China
- Department of Neurosurgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210006, China
| | - Youwu Fan
- Nanjing Medical University, 210000, Nanjing, JiangSu, China
- Department of Neurosurgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210006, China
| |
Collapse
|
2
|
Chen H, Xie H, Wang P, Yan S, Zhang Y, Wang G. A 25 Immune-Related Gene Pair Signature Predicts Overall Survival in Cervical Cancer. Cancer Inform 2022; 21:11769351221090921. [PMID: 35464777 PMCID: PMC9021468 DOI: 10.1177/11769351221090921] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2021] [Accepted: 03/11/2022] [Indexed: 12/24/2022] Open
Abstract
Mounting evidence suggests that the tumor microenvironment plays an important role in the occurrence and development of cancer, with immune system dysfunction being closely related to malignant cancers. We aimed to screen immune-related genes (IRGs) to generate an IRG pair (IRGP)-based prognostic signature for cervical cancer (CC). Datasets were obtained from The Cancer Genome Atlas and Gene Expression Omnibus databases and used as training and validation cohorts, respectively. Using the ImmPort database, IRGs in control and CC samples were compared, and differentially expressed genes were identified to construct an IRGP prognostic signature. Based on this analysis, 25 IRGPs were identified as important factors for the prognosis of CC. Univariate and multivariate Cox regression analyses further showed that the IRGP signature was an independent prognostic factor of overall survival. In summary, we successfully constructed an IRGP prognostic signature of CC, providing insights into immunotherapy for CC.
Collapse
Affiliation(s)
- Huaqiu Chen
- School of Clinical Medicine, Dali University, Yunnan, China.,Xichang People's Hospital, Sichuan, China
| | - Huanyu Xie
- Xichang People's Hospital, Sichuan, China
| | - Pengyu Wang
- School of Clinical Medicine, Dali University, Yunnan, China
| | - Shanquan Yan
- School of Clinical Medicine, Dali University, Yunnan, China
| | - Yuanyuan Zhang
- School of Clinical Medicine, Dali University, Yunnan, China
| | - Guangming Wang
- School of Clinical Medicine, Dali University, Yunnan, China
| |
Collapse
|